INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Mutation of Rv2887, a marR-like gene, confers Mycobacterium tuberculosis resistance to an imidazopyridine-based agent.

Show full item record

Bookmark or cite this item: http://hdl.handle.net/10027/20533

Files in this item

File Description Format
PDF Mutation of Rv2887.pdf (2MB) Main Article PDF
Title: Mutation of Rv2887, a marR-like gene, confers Mycobacterium tuberculosis resistance to an imidazopyridine-based agent.
Author(s): Winglee, K; Lun, S; Pieroni, M; Kozikowski, A; Bishai, W
Abstract: Drug resistance is a major problem in Mycobacterium tuberculosis control, and it is critical to identify novel drug targets and new antimycobacterial compounds. We have previously identified an imidazo[1,2-a]pyridine-4-carbonitrile-based agent, MPIII-71, with strong activity against M. tuberculosis. In this study, we evaluated mechanisms of resistance to MP-III-71. We derived three independent M. tuberculosis mutants resistant to MP-III-71 and conducted whole-genome sequencing of these mutants. Loss-of-function mutations in Rv2887 were common to all three MP-III-71-resistant mutants, and we confirmed the role of Rv2887 as a gene required for MP-III-71 susceptibility using complementation. The Rv2887 protein was previously unannotated, but domain and homology analyses suggested it to be a transcriptional regulator in the MarR (multiple antibiotic resistance repressor) family, a group of proteins first identified in Escherichia coli to negatively regulate efflux pumps and other mechanisms of multidrug resistance. We found that two efflux pump inhibitors, verapamil and chlorpromazine, potentiate the action of MP-III-71 and that mutation of Rv2887 abrogates their activity. We also used transcriptome sequencing (RNA-seq) to identify genes which are differentially expressed in the presence and absence of a functional Rv2887 protein. We found that genes involved in benzoquinone and menaquinone biosynthesis were repressed by functional Rv2887. Thus, inactivating mutations of Rv2887, encoding a putative MarR-like transcriptional regulator, confer resistance to MP-III-71, an effective antimycobacterial compound that shows no cross-resistance to existing antituberculosis drugs. The mechanism of resistance of M. tuberculosis Rv2887 mutants may involve efflux pump upregulation and also drug methylation.
Issue Date: 2015-11
Publisher: American Society for Microbiology
Citation Info: Winglee, K., Lun, S., Pieroni, M., Kozikowski, A. and Bishai, W. Mutation of Rv2887, a marR-Like gene, confers mycobacterium tuberculosis resistance to an imidazopyridine-based agent. Antimicrobial Agents and Chemotherapy. 2015. 59(11): 6873-6881. doi: 10.1128/AAC.01341-15.
Type: Article
Description: This is a copy of an article published in Antimicrobial Agents and Chemotherapy © 2015 American Society for Microbiology Publications. © Winglee et al.
URI: http://hdl.handle.net/10027/20533
ISSN: 0066-4804
Sponsor: We acknowledge National Institutes of Health grants AI39856, AI36973,and AI097138 and the Howard Hughes Medical Institute for funding this work.
Date Available in INDIGO: 2016-05-06
 

This item appears in the following Collection(s)

Show full item record

Statistics

Country Code Views
United States of America 88
China 56
Russian Federation 17
Ukraine 16
Germany 4

Browse

My Account

Information

Access Key